Debiopharm
Min Ma is a Senior Scientist in Translational Pharmacology at Debiopharm since October 2024, with a substantial background in cancer research and pharmacology. Previous roles include Senior Investigator at Ichnos Sciences and a Scientific Collaborator at the University of Lausanne, where significant contributions were made in characterizing the Androgen receptor in melanoma, managing biobanks, and developing biosensors for kinase activity quantification. Min Ma has published numerous first-author papers and holds a PhD in Cell/Cellular and Molecular Biology from the University of Bern, alongside an MS in Applied Biotechnology from Uppsala University and a BS in Biology from Nanjing Agricultural University. Early research experience includes a postdoctoral fellowship at Kinderspital Zürich and studies on Theileria annulata during graduate studies.
This person is not in the org chart
This person is not in any teams
Debiopharm
2 followers
Debiopharm Group is a biopharmaceutical development specialist that in-licenses promising biologics and small molecule drug candidates. They develop their products for global registration and maximum commercial potential for out-licensing to pharmaceutical partners for sales and marketing.